...
首页> 外文期刊>Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis >Pre-thrombotic state and impaired fibrinolytic potential in coronary heart disease patients with left ventricular dysfunction.
【24h】

Pre-thrombotic state and impaired fibrinolytic potential in coronary heart disease patients with left ventricular dysfunction.

机译:左心功能不全的冠心病患者的血栓前状态和纤溶潜能受损。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Patients with coronary heart disease (CHD) are at considerable risk for recurrent ischaemic events. A pre-thrombotic state and/or impaired fibrinolysis might play an important role in causing recurrent ischaemic events. Two hundred and fifty-seven CHD patients underwent the dobutamine stress echocardiography test (DSE) to investigate the possible presence of inducible ischaemia; 89 patients showed evidence of stunned and/or necrotic myocardium (resting wall motion abnormalities). Factor VIII activity and fibrinogen levels were significantly higher in patients with stunnedecrotic myocardium than in CHD patients with normal resting wall motions (factor VIII activity, = 0.004; fibrinogen, = 0.04). Of interest, after stimulating the fibrinolytic system with the DSE test, plasminogen activator inhibitor-1 activity was significantly higher in patients with necrotic/stunned myocardium than in patients with resting normal wall motion ( = 0.03), whereas tissue-type plasminogen activator activity after the DSEtest was significantly lower in patients with stunnedecrotic myocardium than in patients with normal wall motion ( = 0.001). Overall, 30 CHD patients developed induced ischaemia (new wall motion abnormalities) during the DSE test. CHD patients with stunned and/or necrotic myocardium presented decreased fibrinolytic potential and the presence of a hypercoagulable state due to increased factor VIII activity, and fibrinogen levels. Therefore, these CHD patients must be considered at high risk of re-developing coronary thrombosis and might benefit from a more aggressive anticoagulant therapy.
机译:患有冠心病(CHD)的患者极有发生复发性缺血事件的风险。血栓前状态和/或纤维蛋白溶解受损可能在引起缺血再发中起重要作用。 257名冠心病患者接受了多巴酚丁胺负荷超声心动图测试(DSE),以研究是否存在诱导型缺血。 89例患者显示出心肌震惊和/或坏死(壁运动异常)的证据。震惊/坏死性心肌病患者的VIII因子活性和纤维蛋白原水平显着高于静息壁运动正常的CHD患者(VIII因子活性= 0.004;纤维蛋白原= 0.04)。有趣的是,在用DSE试验刺激纤溶系统后,坏死性/震惊心肌病患者的纤溶酶原激活物抑制剂1活性显着高于静息正常壁运动的患者(= 0.03),而组织型纤溶酶原激活物活性在震惊/坏死心肌的DSE测试显着低于壁运动正常的患者(= 0.001)。总体上,在DSE测试期间,有30名CHD患者发生了诱导的局部缺血(新壁运动异常)。患有震惊和/或坏死心肌的冠心病患者由于凝血因子VIII活性和纤维蛋白原水平的升高,其纤维蛋白溶解潜能降低,并出现高凝状态。因此,必须考虑将这些冠心病患者重新发展为冠状动脉血栓的高风险,并且可能会从更积极的抗凝治疗中受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号